Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Central Abdominal Bulging: later-stage trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Central Abdominal Bulging: 1 US clinical trial tracked, none currently recruiting.

Central Abdominal Bulging is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Evofem, running 1 of these trials.

Enrollment posture brief

Registry condition central-abdominal-bulging

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Central Abdominal Bulgin (this)Central Abdominal Bulgin (th…0%
Open-enrollment share among volume-matched conditions near Central Abdominal Bulging

Central Abdominal Bulging has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Central Abdominal Bulging on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Central Abdominal Bulging is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Evofem 1 trials

Named interventions

Most-linked intervention names on Central Abdominal Bulging records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

LIPO-202 Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Central Abdominal Bulging trials. A trial with sites in several states counts in each.

Massachusetts 1 trials
Indiana 1 trials
Illinois 1 trials
Florida 1 trials
Connecticut 1 trials
Colorado 1 trials
California 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Central Abdominal Bulging page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Central Abdominal Bulging trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Evofem sponsors the most Central Abdominal Bulging trials on record, review their full trial history before evaluating a specific study. See Evofem's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Central Abdominal Bulging condition card totals 1 registered trials; most-linked intervention LIPO-202; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.